Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > BioSante Pharmaceuticals To Present At Investor Conference

February 23rd, 2004

BioSante Pharmaceuticals To Present At Investor Conference

Abstract:
BioSante Pharmaceuticals announced today that Stephen M. Simes, its president and chief executive officer, is scheduled to present at the BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York on Wednesday, February 25, at 9:30 a.m. EST. Mr. Simes will discuss BioSante's progress with its hormone therapy products and its nanotechnology-based drug and vaccine delivery systems.

Source:
Businesswire

Bookmark:

Related News Press

Announcements

Bacterial spare parts filter antibiotic residue from groundwater May 22nd, 2013

UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013

Atomic-Scale Investigations Solve Key Puzzle of LED Efficiency: MIT and Brookhaven Lab scientists use electron microscopy imaging techniques to settle a solid-state controversy and raise new experimental possibilities May 22nd, 2013

Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013